• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-33 与先天淋巴细胞的功能

Interleukin-33 and the function of innate lymphoid cells.

机构信息

Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow Biomedical Research Centre, 120 University Place, Glasgow G12 8TA, UK.

出版信息

Trends Immunol. 2012 Aug;33(8):389-96. doi: 10.1016/j.it.2012.04.005. Epub 2012 May 19.

DOI:10.1016/j.it.2012.04.005
PMID:22609147
Abstract

Interleukin (IL)-33 is a member of the IL-1 cytokine family that has been shown to play an important role in the induction and effector phases of type 2 immune responses. Both innate and adaptive immunity are regulated by IL-33, and many studies have shown disease-associated functions for this cytokine. Recently, IL-33 has been implicated in the function of novel innate lymphocyte populations that regulate both protective responses in parasitic infections and allergic airway inflammation. Here, we discuss recent data highlighting the dual roles of IL-33 in protective and deleterious immune responses.

摘要

白细胞介素 (IL)-33 是 IL-1 细胞因子家族的一员,它在 2 型免疫反应的诱导和效应阶段发挥着重要作用。IL-33 调节先天免疫和适应性免疫,许多研究表明该细胞因子与疾病相关功能有关。最近,IL-33 被牵连到新型先天淋巴细胞群的功能中,这些细胞群调节寄生虫感染中的保护性反应和过敏性气道炎症。在这里,我们讨论了最近的数据,这些数据强调了 IL-33 在保护性和有害免疫反应中的双重作用。

相似文献

1
Interleukin-33 and the function of innate lymphoid cells.白细胞介素-33 与先天淋巴细胞的功能
Trends Immunol. 2012 Aug;33(8):389-96. doi: 10.1016/j.it.2012.04.005. Epub 2012 May 19.
2
IL-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma.白细胞介素-2 家族细胞因子白细胞介素-9 和白细胞介素-21 可调节哮喘中的先天和适应性 2 型免疫反应。
J Allergy Clin Immunol. 2024 Nov;154(5):1129-1145. doi: 10.1016/j.jaci.2024.07.024. Epub 2024 Aug 13.
3
Group 2 innate lymphoid cells in health and disease.健康与疾病中的2型固有淋巴细胞
Cold Spring Harb Perspect Biol. 2015 Jan 8;7(5):a016337. doi: 10.1101/cshperspect.a016337.
4
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.CD4(+) 淋巴组织诱导细胞促进肠道固有免疫。
Immunity. 2011 Jan 28;34(1):122-34. doi: 10.1016/j.immuni.2010.12.009. Epub 2010 Dec 30.
5
IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.IL-33 反应性谱系 CD25+ CD44(hi) 淋巴样细胞在肺部介导先天 2 型免疫和过敏炎症。
J Immunol. 2012 Feb 1;188(3):1503-13. doi: 10.4049/jimmunol.1102832. Epub 2011 Dec 23.
6
IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.IL-33:一种警报素细胞因子,在先天免疫、炎症和过敏反应中具有关键作用。
Curr Opin Immunol. 2014 Dec;31:31-7. doi: 10.1016/j.coi.2014.09.004. Epub 2014 Sep 29.
7
Lung ILC2s link innate and adaptive responses in allergic inflammation.肺 ILC2 细胞连接过敏炎症中的先天和适应性反应。
Trends Immunol. 2015 Mar;36(3):189-95. doi: 10.1016/j.it.2015.01.005. Epub 2015 Feb 19.
8
IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure.IL-33 和胸腺基质淋巴细胞生成素介导对慢性空气传播过敏原暴露的免疫病理学反应。
J Immunol. 2014 Aug 15;193(4):1549-59. doi: 10.4049/jimmunol.1302984. Epub 2014 Jul 11.
9
IL-27: a double agent in the IL-6 family.IL-27:IL-6 家族中的双面间谍。
Clin Exp Immunol. 2018 Jul;193(1):37-46. doi: 10.1111/cei.13116. Epub 2018 Mar 9.
10
IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.IL-33 介导体液免疫和适应性免疫细胞促进蛋白酶过敏原诱导的过敏性气道炎症的最大反应。
J Immunol. 2013 May 1;190(9):4489-99. doi: 10.4049/jimmunol.1201212. Epub 2013 Apr 1.

引用本文的文献

1
Determining the toxicological effects of indoor air pollution on both a healthy and an inflammatory-comprised model of the alveolar epithelial barrier in vitro.测定室内空气污染对体外健康和肺泡上皮屏障炎症模型的毒理学影响。
Part Fibre Toxicol. 2024 May 17;21(1):25. doi: 10.1186/s12989-024-00584-8.
2
Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin.阻断簇 2 固有淋巴细胞的激活和巨噬细胞 M2 极化:毛蕊异黄酮通过调控这些细胞在卵清蛋白诱导的变应性哮喘中的作用机制。
BMC Pharmacol Toxicol. 2024 Apr 22;25(1):30. doi: 10.1186/s40360-024-00751-9.
3
Neuroinflammation and anti-inflammatory therapy for ischemic stroke.
缺血性中风的神经炎症与抗炎治疗
Heliyon. 2023 Jul 6;9(7):e17986. doi: 10.1016/j.heliyon.2023.e17986. eCollection 2023 Jul.
4
Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review.解锁中风血液生物标志物的潜力:早期诊断、缺血与出血性鉴别和出血性转化风险:全面综述。
Int J Mol Sci. 2023 Jul 17;24(14):11545. doi: 10.3390/ijms241411545.
5
The role of regulatory T cells and follicular T helper cells in HBV infection.调节性 T 细胞和滤泡辅助 T 细胞在乙型肝炎病毒感染中的作用。
Front Immunol. 2023 May 19;14:1169601. doi: 10.3389/fimmu.2023.1169601. eCollection 2023.
6
The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy.IL-33/ST2 在 COPD 中的作用及其作为抗体治疗的未来。
Int J Mol Sci. 2023 May 12;24(10):8702. doi: 10.3390/ijms24108702.
7
Role of Fibroblasts in Chronic Inflammatory Signalling in Chronic Rhinosinusitis with Nasal Polyps-A Systematic Review.成纤维细胞在伴鼻息肉的慢性鼻-鼻窦炎慢性炎症信号传导中的作用——一项系统评价
J Clin Med. 2023 May 4;12(9):3280. doi: 10.3390/jcm12093280.
8
Exosomes from bone marrow mesenchymal stem cells are a potential treatment for ischemic stroke.骨髓间充质干细胞来源的外泌体是缺血性中风的一种潜在治疗方法。
Neural Regen Res. 2023 Oct;18(10):2246-2251. doi: 10.4103/1673-5374.369114.
9
A biomarker for bacteremia in pregnant women with acute pyelonephritis: soluble suppressor of tumorigenicity 2 or sST2.急性肾盂肾炎孕妇菌血症的生物标志物:可溶性肿瘤抑制因子 2 或 sST2。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183470. doi: 10.1080/14767058.2023.2183470.
10
Cerebrospinal fluid levels of sortilin-1, lipocalin-2, autotaxin, decorin and interleukin-33 in patients with idiopathic intracranial hypertension.特发性颅内高压患者脑脊液中 sortilin-1、脂联素-2、自分泌运动因子、核心蛋白聚糖和白细胞介素-33 的水平。
Arq Neuropsiquiatr. 2022 Oct;80(10):1011-1016. doi: 10.1055/s-0042-1758559. Epub 2022 Dec 19.